Skip to main content
OpenTrials

Clinical trial condition

Tic Disorders

Explore clinical trials studying Tic Disorders. Study availability and eligibility vary by location and protocol.

114 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Tic Disorders trial results

Completed

Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

NCT03444038

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Neurocrine Clinical Site Sun City, Arizona, United States
  • Neurocrine Clinical Site Anaheim, California, United States
  • Neurocrine Clinical Site San Diego, California, United States
  • Neurocrine Clinical Site Santa Ana, California, United States
View all 37 locations
View Trial Details
Completed

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

NCT03571256

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Teva Investigational Site 060-0160 Gainesville, Florida, United States
  • Teva Investigational Site 060-0166 Gulf Breeze, Florida, United States
  • Teva Investigational Site 060-0161 Miami, Florida, United States
  • Teva Investigational Site 060-0151 Orlando, Florida, United States
View all 56 locations
View Trial Details
Completed

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

NCT03452943

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Teva Investigational Site 046-0104 Dothan, Alabama, United States
  • Teva Investigational Site 046-0117 Sun City, Arizona, United States
  • Teva Investigational Site 046-0107 Rogers, Arkansas, United States
  • Teva Investigational Site 046-0126 Anaheim, California, United States
View all 42 locations
View Trial Details
Completed

Guanfacine in Children With Tic Disorders

NCT01547000

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • Yale Child Study Center New Haven, Connecticut, United States
  • University of South Florida Tampa, Florida, United States
  • Mount Sinai School of Medicine New York, United States
View Trial Details
Completed

Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

NCT03325010

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Neurocrine Clinical Site Sun City, Arizona, United States
  • Neurocrine Clinical Site Rogers, Arkansas, United States
  • Neurocrine Clinical Site Anaheim, California, United States
  • Neurocrine Clinical Site San Diego, California, United States
View all 35 locations
View Trial Details

Related conditions